Investment
Features
FeesSafety
Academy
More
Pluang+

Compare ADMA Biologics Inc (ADMA) vs Oxford Lane Capital Corp (OXLC) Price & Performance

ADMA Biologics IncTrade
Oxford Lane Capital CorpTrade

Price performance (Past 24H)

Key statistics

ADMA Biologics Inc vs Oxford Lane Capital Corp — how do they compare? ADMA Biologics Inc trades at $9.81 (market cap $2.22B), while Oxford Lane Capital Corp trades at $9.38 (market cap $909.61M). The key difference: ADMA Biologics Inc is far larger — about 2.4× Oxford Lane Capital Corp's market cap, and Oxford Lane Capital Corp pays a 25.76% dividend while ADMA Biologics Inc pays none. Which is the better fit depends on your goals.

ADMAOXLC
Market Cap
$2.22B$909.61M
Sector
HealthFinancials
52-Week High
$20.38$18.75
52-Week Low
$7.60$8.15
Enterprise Value
$2.29B
Dividend Yield
25.76%

Returns comparison

Trailing returns across standard periods

About ADMA Biologics Inc

ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.

Read more on ADMA

About Oxford Lane Capital Corp

Oxford Lane Capital Corp. is a non-diversified, closed-end management investment company. Its primary investment objective is to achieve high current income, with a secondary objective of capital appreciation. The company primarily invests in equity and junior debt tranches of collateralized loan obligations (CLOs), which are pools of corporate loans. OXLC is known for its high-yield distribution policy and provides investors with leveraged exposure to the CLO market.

Read more on OXLC